Odell Joseph Dean Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2516 Broadmoor Blvd, Monroe, LA 71201 Phone: 318-807-1390 Fax: 318-807-1394 |
Robert L Humble, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2516 Broadmoor Blvd, Monroe, LA 71201 Phone: 318-807-1390 Fax: 318-807-1394 |
Dr. Arthur E Liles, MD Urology Medicare: Medicare Enrolled Practice Location: 2516 Broadmoor Blvd, Monroe, LA 71201 Phone: 318-387-9420 Fax: 318-323-8216 |
Dr. Jon Bradley Johnson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2516 Broadmoor Blvd, Monroe, LA 71201 Phone: 318-387-9420 Fax: 318-323-8216 |
Dr. Don F Marx, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 3510 Magnolia Cv, Suite 170, Monroe, LA 71203 Phone: 318-387-9774 Fax: 318-322-7306 |
Dr. John Michael Cage, MD Urology Medicare: Medicare Enrolled Practice Location: 312 Grammont St Ste 411, Monroe, LA 71201 Phone: 318-966-6622 Fax: 318-966-6621 |
News Archive
A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The vaccine BM32 is based on an innovative recombinant peptide carrier technology that allows for fewer injections and shows fewer side effects compared with other immunotherapy treatments for allergy sufferers. BM32 has been developed by Biomay AG, an Austrian biopharmaceutical company specialized in the discovery and development of innovative allergy therapeutics. The company has already initiated a Phase IIb trial for BM32 with 180 allergic patients.
What the Supreme Court decides will impact the billions of dollars that have already been spent to implement the measure, as well as consumers, employers, small businesses, the health care industry, the insurance marketplace, and, of course, politics and K Street.
Two major eye diseases and leading causes of blindness—age-related macular degeneration and diabetic retinopathy can be reversed or even prevented by drugs that activate a protein found in blood vessel cells, researchers at the University of Utah School of Medicine and several other institutions have announced in a new study.
An international group of researchers has shown that a regulatory protein involved in controlling how cancer spreads through the body also influences the fate of stem cells in the intestine of mice. The results, which are published in The EMBO Journal, show that the Snai1 protein plays an important role in deciding the fate of intestinal stem cells and the different functions that these cells can adopt.
› Verified 7 days ago